X (Reuters) – The U.S. Food and Drug Administration on Friday authorized two COVID-19 vaccines for millions of the youngest American children.
The agency authorized Moderna Inc’s shot for children aged 6 months to 17 years old, and Pfizer-BioNTech’s vaccine for children aged 6 months to 4 years of age.
(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)